X T L Biopharmaceuticals Ltd (NASDAQ:XTLB)

1.95
Delayed Data
As of May 25
 -0.003 / -0.15%
Today’s Change
1.55
Today|||52-Week Range
4.14
-14.74%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Operating ActivitiesNet Income / Starting Line-2.8M-4.3M-2.6M-786.5K
 
 
 
 
 
Depreciation52.3K7.0K3.0K1.0K
 
 
 
 
 
Total Other Cash Flow500.8K2.5M1.0M-395.8K
 
 
 
 
 
Funds From Operations-2.3M-1.8M-1.5M-1.2M
 
 
 
 
 
Funds From/For Other Operating Expenses163.7K16.0K220.7K-52.4K
 
 
 
 
 
Net Cash Flow - Operating Activities-2.4M-1.9M-1.7M-1.1M
 
 
 
 
 
 
InvestingIncrease In Investments0.00-10.0K0.000.00
 
 
Decrease In Investments1.5M21.0K0.000.00
 
 
 
Capital Expenditures-7.9K-2.0K-2.0K0.00
 
 
 
 
Fixed Asset Disposal0.000.000.001.0K
 
 
Net Assets From Acquisitions 0.00-55.0K0.000.00
 
 
Net Cash Flow Investing1.5M-110.0K-66.2K1.0K
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.00----
Long Term Borrowings0.000.000.000.00--
Long Term Debt Reduction0.000.000.000.00--
Net Proceeds Stock Sale304.6K3.6M0.004.9M
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing0.0020.0K0.000.00
 
 
Other Uses - Financing0.000.000.000.00--
Net Cash Flow - Financing304.6K3.6M0.004.9M
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash-13.8K-2.0K---2.0K
 
 
 
 
 
Net Change In Cash-652.7K1.6M-1.8M3.8M